• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Anthem Inc.

Anthem, Apple to launch asthma study

September 16, 2020 By Sean Whooley

Anthem (NYSE:ANTM) announced today that it is collaborating with Apple (NSDQ:AAPL) on a study using smart devices to manage asthma. Indianapolis-based Anthem and Apple are planning on examining how the use of everyday devices like the Apple Watch and iPhone can help individuals with asthma better self-manage their condition in search of improved clinical outcomes, according to […]

Filed Under: Big Data, Clinical Trials, Health Technology, Respiratory, Software / IT Tagged With: Anthem Inc., Apple, CareEvolution

Globus Medical lands Anthem coverage win for Secure-C spinal implant

January 28, 2019 By Brad Perriello

Globus Medical (NYSE:GMED) last week said it won a coverage decision for its Secure-C cervical spine implant from health insurance giant Anthem (NYSE:ANTM). Audubon, Pa.-based Globus said the decision means the device is covered by the major third-party payers in all 50 states. Anthem has more than 73 million lives under its coverage umbrella, according to Globus. The Secure-C […]

Filed Under: Orthopedics, Spine, Wall Street Beat Tagged With: Anthem Inc., Globus Medical, Reimbursement

Anthem, Novo Nordisk team up for real-world diabetes drug study

October 17, 2018 By Sarah Faulkner

Anthem’s outcomes research unit, HealthCore, and Novo Nordisk (NYSE:NVO) have joined forces to study Novo Nordisk’s semaglutide GLP-1 receptor agonist in people with Type 2 diabetes. The real-world trial is designed to compare the long-term effectiveness of the drug, also known as Ozempic, against 40 other medications among 2,250 adults with Type 2 diabetes. Get the full story […]

Filed Under: Clinical Trials, Diabetes, Pharmaceutical, Wall Street Beat Tagged With: Anthem Inc., Novo Nordisk

Anthem adds Intersect ENT’s Sinuva implant to formulary

October 2, 2018 By Sarah Faulkner

Anthem this month added Intersect ENT‘s (NSDQ:XENT) Sinuva steroid-releasing implant to its updated formulary as a Tier 3 product, according to a note from Leerink analysts. The product is designated on Anthem’s formulary as “LD” – limited distribution – and is only available to certain pharmacies or wholesalers. Intersect ENT launched the product in the U.S. in April this year. Get the […]

Filed Under: Drug-Device Combinations, Otolaryngology/Ear, Nose & Throat (ENT), Pharmaceutical, Wall Street Beat Tagged With: Anthem Inc., intersectent

Anthem exec chairman joins Proteus board | Personnel Moves – Feb. 26, 2018

February 26, 2018 By Sarah Faulkner

Proteus Digital Health announced earlier this month that Anthem‘s (NYSE:ANTM) executive chairman, Joseph Swedish, joined the company’s board of directors. Swedish served as Anthem’s president & chief executive from 2013 until he was appointed executive chairman in 2018. Get the full story at our sister site, Drug Delivery Business News.

Filed Under: Drug-Device Combinations, Pharmaceutical, Wall Street Beat Tagged With: Aerie Pharmaceuticals, Allergan, Anthem Inc., BioCorRx, BrainStorm Cell Therapeutics Inc., Chrono Therapeutics, InfuSystem, Proteus Digital Health, Reva Medical Inc.

JDRF touts win after Anthem decides to cover artificial pancreas systems

November 17, 2017 By Sarah Faulkner

JDRF said today it successfully persuaded Anthem to cover artificial pancreas systems, after meeting the health insurer as part of its Coverage2Control campaign. America’s 25 largest health insurers now cover Medtronic‘s (NYSE:MDT) MiniMed system, according to the organization. Get the full story at our sister site, Drug Delivery Business News.

Filed Under: Diabetes, Drug-Device Combinations, Pharmaceutical, Wall Street Beat Tagged With: Anthem Inc., Juvenile Diabetes Research Foundation (JDRF), Medtronic

Boehringer Ingelheim, Anthem partner for largest real-world COPD trial

October 12, 2017 By Sarah Faulkner

As part of a research collaboration launched in 2014, Boehringer Ingelheim and Anthem have partnered to study people with chronic obstructive pulmonary disease in real-world settings to assess how commonly-prescribed drugs may reduce the occurrence of COPD exacerbations. The team, which also includes Anthem’s outcomes research subsidiary HealthCore, plans to investigate whether adding an inhaled corticosteroid to […]

Filed Under: Clinical Trials, Drug-Device Combinations, Pharmaceutical, Respiratory, Wall Street Beat Tagged With: Anthem Inc., Boehringer Ingelheim Pharmaceuticals

Experts: 2015 could be ‘Year of the Healthcare Hack’

February 11, 2015 By MassDevice Leave a Comment

Experts: 2015 could be 'Year of the Healthcare Hack'

(Reuters) — Security experts are warning healthcare and insurance companies that 2015 will be the "Year of the Healthcare Hack," as cybercriminals are increasingly attracted to troves of personal information held by U.S. insurers and hospitals that command high prices on the underground market.

Filed Under: News Well Tagged With: Anthem Inc., Cybersecurity, stjudemedical

Hackers hit health insurer Anthem in massive cybersecurity breach

February 6, 2015 By MassDevice Leave a Comment

Hackers hit health insurer Anthem in massive cybersecurity breach

(Reuters) — Hackers have stolen personal information relating to current and former customers and staff of No. 2 U.S. health insurer Anthem Inc., after breaching an IT system containing data on up to 80 million people, the company said late yesterday.

Filed Under: News Well Tagged With: Anthem Inc., Cybersecurity

Primary Sidebar

DeviceTalks Weekly

May 20, 2022
DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS